Show simple item record

AuthorIqbal, Heba
AuthorFernandes, Queenie
AuthorIdoudi, Sourour
AuthorBasineni, Renuka
AuthorBilla, Nashiru
Available date2024-04-24T09:53:23Z
Publication Date2024
Publication NamePolymers
ResourceScopus
ISSN20734360
URIhttp://dx.doi.org/10.3390/polym16030386
URIhttp://hdl.handle.net/10576/54201
AbstractAdditive manufacturing (AM) or 3D printing (3DP) is arguably a versatile and more efficient way for the production of solid dosage forms such as tablets. Of the various 3DP technologies currently available, fused deposition modeling (FDM) includes unique characteristics that offer a range of options in the production of various types of tablets. For example, amorphous solid dispersions (ASDs), enteric-coated tablets or poly pills can be produced using an appropriate drug/polymer combination during FDM 3DP. The technology offers the possibility of evolving personalized medicines into cost-effective production schemes at pharmacies and hospital dispensaries. In this review, we highlight key FDM features that may be exploited for the production of tablets and improvement of therapy, with emphasis on gastrointestinal delivery. We also highlight current constraints that must be surmounted to visualize the deployment of this technology in the pharmaceutical and healthcare industries.
SponsorOpen access publication fee was funded by Qatar National Library.
Languageen
PublisherMultidisciplinary Digital Publishing Institute (MDPI)
Subjectamorphous solid dispersion
fused deposition modeling
pharmaceutical
polymer
solubility
three-dimensional printing
TitleStatus of Polymer Fused Deposition Modeling (FDM)-Based Three-Dimensional Printing (3DP) in the Pharmaceutical Industry
TypeArticle Review
Issue Number3
Volume Number16
dc.accessType Open Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record